fda semaglutide obesity U.S. | The FDA has approved a new higher dose (7.2 mg) of Wegovy ( semaglutide) injection, Wegovy HD, for weight loss and long-term weight Wegovy® – A New Treatment

Most studies consist of small human pilot studies conducted in the 1980s and a large body of animal preclinical data arising after the fact

How the Program Works You can get started in the way thats most convenient for you: Option 1: Online Intake (Recommended) Complete a short medical form (23 minutes) Share your health history and weight loss goals Your information is reviewed by a licensed provider Our team contacts you to schedule next steps Option 2: Book a Consultation Choose your preferred time our team will confirm your appointment Meet with a licensed provider via telehealth Review your goals, medical history, and treatment options What Happens Next Medical Review Your case is evaluated by a licensed provider Eligibility is based on your health profile and clinical guidelines Personalized Treatment Plan Built around your goals and medical history May include: GLP-1 / GIP medications (when appropriate) Nutrition guidance Lifestyle recommendations Prescriptions Sent to your preferred pharmacy Brand-name medications prescribed when appropriate Compounded medications available through licensed 503A pharmacies Ongoing Support Progress is monitored over time Treatment adjusted as needed Continued support from your medical team Weight Loss Medications We May Use When clinically appropriate, your provider may prescribe medications to support appetite control, metabolism, and blood sugar regulation

Star, B

Journal of Clinical and Translational Science , 7 (1), e184

Aesthet Surg J 44(4):NP279306

KLOW is a four-component research blend containing GHK-Cu, BPC-157, TB-500, and KPV